Literature DB >> 10746933

Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.

M V Evans1, M E Andersen.   

Abstract

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) has dose-dependent tissue distribution because of induction of CYP1A2, a TCDD-binding protein, in the liver. Induction requires transcriptional activation of the CYP1A2 gene product by TCDD and the Ah receptor. An empirical model for dose-dependent distribution (Carrier et al., 1995, Toxicol. Appl. Pharmacol. 131, 253-266) included two simple descriptors: one for the maximum liver sequestration (Fmax) and the other for body burden leading to half maximum sequestration (Kd). Physiologically based pharmacokinetic (PBPK) models include specific parameters for protein receptors, protein binding, tissue solubility, and protein induction. We have applied a PBPK model to define two macroscopic constants related to these dose-response curves, i.e., the inflection point, and the maximum values of these curves. The dose-response curves generated from the PBPK model were for the proportion sequestered in liver and the liver to fat concentration ratio. Our analysis assessed the specific biological factors in the PBPK model that governed the values of these two macroscopic constants. For the fraction in liver, the Hill coefficient (a shape exponent describing the relationship between the Ah receptor-TCDD complex with the DNA receptor) resulted in the largest shift in inflection when using PBPK model parameters specific for TCDD. For the liver to fat ratio, the inflection point was most affected by the number of available Ah receptors. Conventional normalized sensitivity coefficients for the liver-to-fat ratio at the maximum were highest for the fat-to-blood partition coefficient, CYP1A2 binding affinity, and maximum extent of induction of CYP1A2. A similar pattern was observed for the liver fraction, except that the sensitivity coefficients were much smaller. The behavior of different TCDD congeners was evaluated by altering the value of key parameters. Our results demonstrate that the inflection point is more related to characteristics of DNA binding/induction steps of the Ah receptor-DNA complex than by the CYP1A2 affinity of TCDD or concentrations of CYP1A2. Surprisingly, the maximum is more sensitive to changes in CYP1A2 concentrations and affinity for TCDD. In addition, the analysis showed that the liver-to-fat ratio is a more useful experimental measure than is proportion in liver because the ratio responds with similar sensitivity over a much wider range of input parameters.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10746933     DOI: 10.1093/toxsci/54.1.71

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  25 in total

Review 1.  Whole body pharmacokinetic models.

Authors:  Ivan Nestorov
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Interpretation of studies on the developmental reproductive toxicology of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male offspring.

Authors:  David R Bell; Sally Clode; Ming Qi Fan; Alwyn Fernandes; Paul M D Foster; Tao Jiang; George Loizou; Alan MacNicoll; Brian G Miller; Martin Rose; Lang Tran; Shaun White
Journal:  Food Chem Toxicol       Date:  2010-04-11       Impact factor: 6.023

Review 3.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

4.  In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.

Authors:  Rungnapa Boonpawa; Albertus Spenkelink; Ans Punt; Ivonne M C M Rietjens
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

5.  A physiologically based pharmacokinetic model of vitamin D.

Authors:  Megan E Sawyer; Hien T Tran; Marina V Evans
Journal:  J Appl Toxicol       Date:  2017-06-06       Impact factor: 3.446

6.  Study on inter-ethnic human differences in bioactivation and detoxification of estragole using physiologically based kinetic modeling.

Authors:  Jia Ning; Jochem Louisse; Bert Spenkelink; Sebastiaan Wesseling; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2017-03-29       Impact factor: 5.153

7.  Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.

Authors:  Sungkyoon Kim; David Kim; Gary M Pollack; Leonard B Collins; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2009-05-03       Impact factor: 4.219

8.  Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.

Authors:  Frederique Fenneteau; Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

9.  The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia.

Authors:  Lisa M Baumann Kreuziger; Gobind Tarchand; Vicki A Morrison
Journal:  Leuk Lymphoma       Date:  2013-05-15

10.  Use of physiologically based biokinetic (PBBK) modeling to study estragole bioactivation and detoxification in humans as compared with male rats.

Authors:  Ans Punt; Alicia Paini; Marelle G Boersma; Andreas P Freidig; Thierry Delatour; Gabriele Scholz; Benoît Schilter; Peter J van Bladeren; Ivonne M C M Rietjens
Journal:  Toxicol Sci       Date:  2009-05-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.